Curis Inc Stock Today
| CRIS Stock | USD 2.84 0.21 7.98% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Curis is selling for under 2.84 as of the 16th of March 2025; that is 7.98 percent increase since the beginning of the trading day. The stock's lowest day price was 2.75. Curis has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 1st of August 2000 | Category Healthcare | Classification Health Care |
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Curis, Inc. was incorporated in 2000 and is headquartered in Lexington, Massachusetts. Curis operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 8.47 M outstanding shares of which 160.75 K shares are currently shorted by private and institutional investors with about 5.21 trading days to cover. More on Curis Inc
Moving together with Curis Stock
Moving against Curis Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Curis Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Thematic Idea | Cancer Fighters (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Cancer Fighters, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsCuris can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Curis' financial leverage. It provides some insight into what part of Curis' total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Curis Inc (CRIS) is traded on NASDAQ Exchange in USA. It is located in Building C, Lexington, MA, United States, 02421 and employs 49 people. Curis is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 24.05 M. Curis Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 8.47 M outstanding shares of which 160.75 K shares are currently shorted by private and institutional investors with about 5.21 trading days to cover.
Curis Inc currently holds about 98.69 M in cash with (38.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.02.
Check Curis Probability Of Bankruptcy
Ownership AllocationThe market capitalization of Curis Inc is $24.05 Million. 30% of Curis Inc outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check Curis Ownership Details
Curis Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Blackrock Inc | 2024-12-31 | 68.3 K | |
| Focused Wealth Strategies, Inc. | 2024-12-31 | 59.2 K | |
| Northern Trust Corp | 2024-12-31 | 47.4 K | |
| Millennium Management Llc | 2024-12-31 | 25.6 K | |
| Engineers Gate Manager Lp | 2024-12-31 | 21.4 K | |
| State Street Corp | 2024-12-31 | 21 K | |
| Franklin Street Advisors Inc. | 2024-12-31 | 20 K | |
| A16z Perennial Management Lp | 2024-12-31 | 13.3 K | |
| Squarepoint Ops Llc | 2024-12-31 | 11.6 K | |
| Maverick Capital Ltd | 2024-12-31 | 631.8 K | |
| M28 Capital Management Lp | 2024-12-31 | 521.1 K |
Curis Historical Income Statement
Curis Stock Against Markets
Curis Corporate Management
| Jonathan Zung | Chief Officer | Profile | |
| Nancy Soohoo | Vice Counsel | Profile | |
| Reinhard MD | Senior Development | Profile | |
| Elif McDonald | VP Communications | Profile | |
| Mark Noel | Vice Property | Profile | |
| Rachel Blasbalg | Senior Resources | Profile |
Additional Tools for Curis Stock Analysis
When running Curis' price analysis, check to measure Curis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curis is operating at the current time. Most of Curis' value examination focuses on studying past and present price action to predict the probability of Curis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curis' price. Additionally, you may evaluate how the addition of Curis to your portfolios can decrease your overall portfolio volatility.